These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32441894)

  • 1. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
    Eyal N
    Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 4. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 5. A call to test new vaccines head to head, in monkeys.
    Cohen J
    Science; 2020 Oct; 370(6513):154-155. PubMed ID: 33033196
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines for COVID-19: The current state of play.
    Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN
    Paediatr Respir Rev; 2020 Sep; 35():43-49. PubMed ID: 32653463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 shot protects monkeys.
    Cohen J
    Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues.
    Kamble PH; Dubhashi SP
    Pan Afr Med J; 2020; 36():206. PubMed ID: 32963672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine trials in Africa.
    Makoni M
    Lancet Respir Med; 2020 Nov; 8(11):e79-e80. PubMed ID: 32896275
    [No Abstract]   [Full Text] [Related]  

  • 14. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.